OptraSCAN® Granted US Patent for Detecting Tissue Area of Interest in Digital Pathology Imaging

The company reports this newly acquired patent pertains to a software system that can detect tissue’s area of interest and can differentiate between a tumor and a non-tumor cell. Furthermore, they believe that this patent is an important milestone in defending their exclusive artificial intelligence and machine learning-based automated image analysis solution; especially created for nuclear & membrane biomarker, immune-oncology, prostate cancer and cytology imaging.

Third Generation On-Demand Digital Pathology® System Launched at USCAP 2018

3/14/18: Reduced scan times and competitive prices with digital microscopes now make Digital Pathology more appealing to mainstream marketplace